Coherus Biosciences Funding: $220M Raised, Series C (2014)
Coherus Biosciences is based in Redwood City. It has raised $220M in total funding. Latest round: Series C.
Coherus Biosciences funding overview
Coherus Biosciences is based in Redwood City. Coherus Biosciences has raised $220M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in May 2014. The round record for Coherus Biosciences runs through 2014; nothing later has been disclosed. Investors on record include KKR & Co. L.P., Venrock, RA Capital Management, Rock Springs Capital, Fidelity Biosciences, Sofinnova Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
Coherus Biosciences at a glance
Total raised
$220M
Latest round
Series C
Latest round date
May 2014
Headquarters
Redwood City
Notable investors
KKR & Co. L.P., Venrock, RA Capital Management, Rock Springs Capital, Fidelity Biosciences, Sofinnova Ventures, Lilly Ventures, Vivo Capital
Frequently asked about Coherus Biosciences funding
How much has Coherus Biosciences raised?
Coherus Biosciences has raised $220M in total disclosed funding across the rounds on record.
Who has invested in Coherus Biosciences?
KKR & Co. L.P., Venrock, RA Capital Management, Rock Springs Capital, Fidelity Biosciences, Sofinnova Ventures are named among the investors backing Coherus Biosciences.
What was the latest Coherus Biosciences funding round?
The most recent disclosed round is a Series C, announced in May 2014.
Where is Coherus Biosciences based?
Coherus Biosciences is based in Redwood City.
When did Coherus Biosciences last raise?
The last disclosed Coherus Biosciences round closed in May 2014 at Series C.
Coherus Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Redwood City below to benchmark round size and investor mix.
